Biotech News
NGM Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference
ir.ngmbio.com2026-05-06 15:00 EST
SOUTH SAN FRANCISCO, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that David J. Woodhouse, Ph.D., Chief Executive Officer, and